Metro

The state’s first company to get a marijuana shop license says it will likely start selling pot in a ‘few weeks’

Keith Bedford/Globe Staff/File

For more stories on the legal marijuana industry, sign up for our newsletter, This Week in Weed.

The Massachusetts Cannabis Control Commission on Monday issued the state’s first license for a recreational pot store, awarding a provisional permit to a medical marijuana dispensary outside Worcester.

The vote marked a milestone in the state’s march to set up a legal commercial marijuana market, though sales to adults who aren’t registered patients are likely weeks away. The dispensary, Cultivate in Leicester, must first pass final inspections, and its owners and managers must complete fingerprint-based background checks.

Still, there is a growing feeling of momentum as the launch of a new era of cannabis commerce comes into view. As of late last week, 32 companies had submitted 63 applications for different marijuana licenses, including those for cultivation, research, manufacturing, transportation, and retail.

Advertisement

“We’re very excited to be the first,” Cultivate president Sam Barber told reporters after the commission voted unanimously to grant his company the provisional license. “We all feel [the marijuana industry] is going to be tremendous for the Commonwealth — the amount of jobs that this is going to create for the local community, especially our town, and the amount of tax revenue is going to be a huge help.”

Get Metro Headlines in your inbox:
The 10 top local news stories from metro Boston and around New England delivered daily.
Thank you for signing up! Sign up for more newsletters here

Massachusetts voters approved recreational marijuana at the ballot box in 2016. State lawmakers then delayed the implementation of commercial sales by six months while they rewrote the law, setting July as the target date for shops to open.

Industry players and cannabis advocates alike have generally praised the Legislature’s revisions, saying they resulted in a better regulatory agency, and the cannabis commission has hit its deadlines.

Still, consumer impatience is growing, as evidenced by a flurry of pointed comments on social media.

Barber, for his part, praised the commission’s “rigorous” licensing process, saying its thorough background checks and regulations had helped make Leicester officials and residents more accepting of his business.

Advertisement

“I’d rather have the program done in the right way [so] everyone feels comfortable with it” than rush to open stores, Barber said, adding that Cultivate was hopeful it would start recreational sales “in the next few weeks.”

“Our team has a tremendous amount of work [ahead] getting ready for this big influx,” Barber said.

One potential speed bump: Any products Cultivate sells must be tested by a licensed laboratory for purity and potency. So far, only two of the state’s four primary labs that test medical marijuana have submitted partial applications for licenses to test products for sale under the commission’s recreational regulations. However, the commission recently voted to put applications from labs at the front of the line for review, and officials expect to resolve the issue soon.

Another wrinkle: Cultivate’s growing and processing operations — located on the same property in Leicester as its dispensary — must receive separate licenses from the commission before they can supply products for sale on the recreational market.

If its retail store gets final approval to go recreational before its own growing and manufacturing operations do, Cultivate could potentially source marijuana products from other suppliers with recreational licenses.

Advertisement

Last week, the commission issued its first provisional license to a cultivation facility in Milford operated by Sira Naturals, another medical marijuana company. (Sira, however, has said it usually doesn’t have much marijuana to spare by the time it stocks the shelves of its three medical dispensaries.)

Cultivate could also ask the state Department of Public Health, which regulates medical marijuana, for permission to transfer some of its inventory from the medical system to the recreational one. That’s allowed under state law, but health officials have yet to detail the precise process for doing so.

David Torrisi, president of the Commonwealth Dispensary Association, a trade group, on Monday accused the DPH of dragging its feet on resolving the transfer issue and a number of similar bureaucratic hurdles related to hybrid recreational-medical shops — such as waiving a requirement that only registered patients and their caregivers can set foot inside a dispensary. Except for those hurdles, he said, medical dispensaries are essentially ready to begin recreational sales as soon as they are licensed and inspected by the cannabis commission.

“I’m not convinced DPH understands the urgency or even cares,” said Torrisi, a former state legislator. “We’re not hearing anything from them.”

A DPH spokeswoman said in a statement last month that the agency was “collaborating and meeting regularly with the Cannabis Control Commission to develop and implement a sound and safe process for the transfer of existing medical plants to adult-use.” The agency did not immediately respond to a request for comment Monday evening about Torrisi’s remarks.

In the meantime, the commission is poised to continue processing license applications from other companies.

“We’re making progress,” commission chairman Steve Hoffman said Monday. “[Today] is a big day, but it’s one of many big days, and we have a lot more big days ahead of us.”

Shawn Collins, the commission’s executive director, said another five or six completed applications are nearly ready to be voted on by the commission, which is scheduled to meet again next Thursday.

The commission on Monday also gave provisional approval to other aspects of Sira Naturals’ operation, unanimously voting to issue licenses for the company to transport marijuana and process it into edibles, lotions, and other cannabis-based products.

Dan Adams can be reached at daniel.adams@globe.com. Follow him on Twitter @Dan_Adams86.